Market Research Logo

Global Microbiome Therapeutics Market Research Report 2018

Global Microbiome Therapeutics Market Research Report 2018

This report studies the Microbiome Therapeutics market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Microbiome Therapeutics market by product type and applications/end industries.

In the last several years, global market of microbiome therapeutics developed rapidly, with an average growth rate of 98%. In 2017, global market size of microbiome therapeutics is nearly 14 M USD.

For developing product, there are 2 products in Phase 3, 7 products in Phase 2, 8 products in Phase 1 and 17 products in Preclinical. The total investment for Microbiome Therapeutics developing is around 293 M USD in 2017.

The major players in global Microbiome Therapeutics market include
Seres Therapeutics
Assembly Biosciences
Synthetic Biologics
Interxon
PureTech
Synlogic
Enterome BioScience
4D Pharma
Second Genome
AOBiome
C3 Jian
Rebiotix
MicroBiome Therapeutics LLC
Metabiomics
Ritter Pharmaceuticals
Symberix
OpenBiome
Azitra
Symbiotix Biotherapies
Osel
Metabogen

Geographically, this report is segmented into several key regions, with market size and R&D investment of microbiome therapeutics in these regions, from 2012 to 2025 (forecast), covering
North America
Europe
Asia Pacific
Other

On the basis on the end users/applications, this report covers
C. difficile Infection (CDI)
Inflammatory Bowel Disease (IBD)
Orphan Drug
Immuno-oncology
Others


1 Microbiome Therapeutics Market Overview
1.1 Microbiome Therapeutics Product Overview
1.2 Microbiome Therapeutics Segment by Application
1.2.1 Global Microbiome Therapeutics R&D Investment and Growth Rate Comparison by Application (2012-2022)
1.2.2 Global Microbiome Therapeutics R&D Investment Market Share by Types in 2016
1.2.3 C. difficile Infection (CDI)
1.2.4 Inflammatory Bowel Disease (IBD)
1.2.5 Orphan Drug
1.2.6 Immuno-oncology
1.3 Microbiome Therapeutics Market by Pipeline
1.4 Global Microbiome Therapeutics Market by Regions (2012-2022)
1.4.1 Global Microbiome Therapeutics Market Size and Growth Rate Comparison by Regions (2012-2022)
1.4.2 North America Microbiome Therapeutics Status and Prospect (2012-2025)
1.4.3 Asia Pacific Microbiome Therapeutics Status and Prospect (2012-2025)
1.4.4 Europe Microbiome Therapeutics Status and Prospect (2012-2025)
1.5 Global Microbiome Therapeutics Market Size (2012-2025)
2 Global Microbiome Therapeutics Market Competition by Manufacturers/Brand
2.1 Global Microbiome Therapeutics Sales and Share by Manufacturers
2.2 Global Microbiome Therapeutics R&D Investment and Share by Manufacturers (2012-2017)
2.3 Manufacturers Microbiome Therapeutics Headquarters, Established Date, Product Types
2.4 Microbiome Therapeutics Market Competitive Situation and Trends
2.4.1 Microbiome Therapeutics R&D Investment Concentration Rate
2.4.2 Microbiome Therapeutics R&D Investment Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 Global Microbiome Therapeutics R&D Investment by Regions (2012-2017)
3.1 Global Microbiome Therapeutics Developer Distribution by Regions
3.2 Global Microbiome Therapeutics R&D Investment and Market Share by Regions (2012-2017)
3.3 Global Microbiome Therapeutics R&D Investment and Growth Rate (2012-2017)
3.4 North America Microbiome Therapeutics R&D Investment and Growth Rate (2012-2017)
3.5 Europe Microbiome Therapeutics R&D Investment and Growth Rate (2012-2017)
4 Global Microbiome Therapeutics Market Size by Regions (2012-2025)
4.1 Global Microbiome Therapeutics Consumption by Regions (2012-2025)
4.2 North America Microbiome Therapeutics Market Size (2012-2025)
4.3 Europe Microbiome Therapeutics Market Size (2012-2025)
4.4 Asia Pacific Microbiome Therapeutics Market Size (2012-2025)
5 Global Microbiome Therapeutics R&D Investment by Application
5.1 Global Major Microbiome Therapeutics Developer Application
5.2 Global Microbiome Therapeutics Investment by Application (2012-2017)
5.3 Global Microbiome Therapeutics Production Growth by Application (2012-2017)
6 Microbiome Therapeutics Market Analysis by Product Pipeline
6.1 Microbiome Therapeutics Market by Pipeline
6.2 Microbiome Therapeutics Product Introduction
6.2.1 Phase 3 Product Introduction
6.2.1.1 SER-109
6.2.1.2 RBX2660
6.2.1.3 RP-G28
6.2.2 Phase 2 Product Introduction
6.2.2.1 ribaxamase
6.2.2.2 SYN-010
6.2.2.3 EB8018
6.2.2.4 SGM-1019
6.2.2.5 Ammonia Oxidizing Bacteria (AOB)
6.2.2.6 C16G2
6.2.2.7 LACTIN-V
6.2.2.8 CBM588
6.2.3 Phase 1 Product Introduction
6.2.3.1 SER-262
6.2.3.2 SER-287
6.2.3.3 ABI-H0731
6.2.3.4 Gemicel
6.2.3.5 AG014
6.2.3.6 VE303
6.2.3.7 Blautix
6.2.3.8 RBX2660
6.2.3.9 RBX7455
7 Analysis of Microbiome Therapeutics Industry Key Manufacturers
7.1 Seres Therapeutics
7.1.1 Company Profile
7.1.2 Product Information
7.1.3 Investment and Investment of R&D
7.2 Assembly Biosciences
7.2.1 Company Profile
7.2.2 Product Information
7.2.3 Investment and Investment of R&D
7.3 Synthetic Biologics
7.3.1 Company Profile
7.3.2 Product Information
7.3.3 Investment and Investment of R&D
7.4 Interxon
7.4.1 Company Profile
7.4.2 Product Information
7.4.3 Investment and Investment of R&D
7.5 PureTech
7.5.1 Company Profile
7.5.2 Product Information
7.5.3 Investment and Investment of R&D
7.6 Synlogic
7.6.1 Company Profile
7.6.2 Product Information
7.6.3 Investment and Investment of R&D
7.7 Enterome BioScience
7.7.1 Company Profile
7.7.2 Product Information
7.7.3 Investment and Investment of R&D
7.8 4D Pharma
7.8.1 Company Profile
7.8.2 Product Information
7.8.3 Investment and Investment of R&D
7.9 Second Genome
7.9.1 Company Profile
7.9.2 Product Information
7.9.3 Investment and Investment of R&D
7.10 AOBiome
7.10.1 Company Profile
7.10.2 Product Information
7.10.3 Investment and Investment of R&D
7.11 C3 Jian
7.11.1 Company Profile
7.11.2 Product Information
7.11.3 Investment and Investment of R&D
7.12 Rebiotix
7.12.1 Company Profile
7.12.2 Product Information
7.12.3 Investment and Investment of R&D
7.13 MicroBiome Therapeutics LLC
7.13.1 Company Profile
7.13.2 Product Information
7.13.3 Investment and Investment of R&D
7.14 Metabiomics
7.14.1 Company Profile
7.14.2 Product Information
7.14.3 Investment and Investment of R&D
7.15 Ritter Pharmaceuticals
7.15.1 Company Profile
7.15.2 Product Information
7.15.3 Investment and Investment of R&D
7.16 Symberix
7.16.1 Company Profile
7.16.2 Product Information
7.16.3 Investment and Investment of R&D
7.17 OpenBiome
7.16.1 Company Profile
7.16.2 Product Information
7.16.3 Investment and Investment of R&D
7.18 Azitra
7.18.1 Company Profile
7.18.2 Product Information
7.18.3 Investment and Investment of R&D
7.19 Symbiotix Biotherapies
7.19.1 Company Profile
7.19.2 Product Information
7.19.3 Investment and Investment of R&D
7.20 Osel
7.20.1 Company Profile
7.20.2 Product Information
7.20.3 Investment and Investment of R&D
7.21 Metabogen
7.21.1 Company Profile
7.21.2 Product Information
7.21.3 Investment and Investment of R&D
8 Microbiome Therapeutics Manufacturing Cost Analysis
8.1 Microbiome Therapeutics R&D Cost Analysis
8.1.1Clinical Phase Costs
8.1.2 Capitalized Costs
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost Analysis
8.2.2.1 USA Labor Cost Analysis
8.2.2.2 Europe Labor Costs Analysis
8.2.2.3 Asia Labor Costs Analysis
8.2.3 Other Costs Analysis
8.2.3.1 USA Cost of Electricity Analysis
8.2.3.2 USA Water Cost Analysis
8.2.3.3 Europe Cost of Electricity Analysis
8.2.3.4 Europe Water Cost Analysis
8.2.3.5 China Cost of Electricity Analysis
8.2.3.6 China Water Cost Analysis
8.2.4 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Microbiome Therapeutics
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Microbiome Therapeutics Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Microbiome Therapeutics Market Forecast (2017-2022)
12.1 Global Microbiome Therapeutics R&D Investment and Market Size Forecast
12.1.1 Global Microbiome Therapeutics R&D Investment and Growth Rate Forecast (2017-2022)
12.1.2 Global Microbiome Therapeutics Market Size and Growth Rate Forecast (2017-2025)
12.2 Global Microbiome Therapeutics R&D Investment Forecast by Regions (2017-2022)
12.2.1 North America Microbiome Therapeutics R&D Investment Forecast (2017-2022)
12.2.2 Europe Microbiome Therapeutics R&D Investment Forecast (2017-2022)
12.3 Global Microbiome Therapeutics Market Size Forecast by Regions (2018-2025)
12.3.1 North America Microbiome Therapeutics Market Size Forecast (2018-2025)
12.3.2 Europe Microbiome Therapeutics Market Size Forecast (2018-2025)
12.3.3 Asia Pacific Microbiome Therapeutics Market Size Forecast (2018-2025)
12.4 Global Microbiome Therapeutics R&D Investment Forecast by Application (2017-2022)
12.5 Global Microbiome Therapeutics Market Size Forecast by Application (2018-2025)
13 Research Findings and Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
List of Tables and Figures
Figure Product Picture of Microbiome Therapeutics
Table Application of Microbiome Therapeutics
Table Global Microbiome Therapeutics R&D Investment (K USD) and Growth Rate Comparison by Types (2012-2022)
Figure Global Microbiome Therapeutics R&D Investment Market Share by Types in 2016
Figure C. difficile Infection (CDI) Examples
Figure Inflammatory Bowel Disease (IBD) Examples
Figure Orphan Drug Examples
Figure Immuno-oncology Examples
Table Microbiome Therapeutics Market by Pipeline
Figure Global Microbiome Therapeutics Market Size (M USD) Comparison and Growth Rate by Regions (2012-2025)
Table Microbiome Therapeutics Market Size (M USD) Comparison by Regions (2012-2025)
Figure North America Microbiome Therapeutics Market Size (M USD) and Growth Rate (2012-2025)
Figure Asia Pacific Microbiome Therapeutics Revenue (M USD) and Growth Rate (2012-2025)
Figure Europe Microbiome Therapeutics Revenue (M USD) and Growth Rate (2012-2025)
Figure Global Microbiome Therapeutics Market Size (M USD) Status and Outlook (2012-2025)
Table Global Microbiome Therapeutics Pipeline of Key Manufacturers in 2017
Table Global Microbiome Therapeutics R&D Investment (K USD) of Key Manufacturers (2016-2017)
Table Global Microbiome Therapeutics R&D Investment Share by Manufacturers (2016-2017)
Figure 2016 Microbiome Therapeutics R&D Investment Share by Manufacturers
Figure 2017 Microbiome Therapeutics R&D Investment Share by Manufacturers
Table Manufacturers Microbiome Therapeutics Headquarters and Established Date
Table Manufacturers Microbiome Therapeutics Product Category
Figure 2016 Microbiome Therapeutics R&D Investment Share by Manufacturers
Figure Microbiome Therapeutics R&D Investment Share of Top 3 Manufacturers
Figure Microbiome Therapeutics R&D Investment Share of Top 5 Manufacturers
Table Mergers & Acquisitions, Expansion
Table Global Microbiome Therapeutics Developer Distribution by Regions in 2017
Figure Global Microbiome Therapeutics Developer Distribution by Regions
Table Global Microbiome Therapeutics R&D Investment (K USD) by Regions (2012-2017)
Table Global Microbiome Therapeutics R&D Investment Market Share by Regions (2012-2017)
Figure Global Microbiome Therapeutics R&D Investment Market Share by Regions (2012-2017)
Figure 2016 Global Microbiome Therapeutics R&D Investment Market Share by Regions
Figure Global Microbiome Therapeutics R&D Investment (K USD) and Growth Rate (2012-2017)
Figure North America Microbiome Therapeutics R&D Investment (K USD) and Growth Rate (2012-2017)
Figure Europe Microbiome Therapeutics R&D Investment (K USD) and Growth Rate (2012-2017)
Table Global Microbiome Therapeutics Market Size (M USD) by Regions (2012-2018)
Table Global Microbiome Therapeutics Market Size (M USD) by Regions (2019-2025)
Table Global Microbiome Therapeutics Consumption Market Share by Regions (2012-2018)
Table Global Microbiome Therapeutics Consumption Market Share by Regions (2019-2025)
Figure Global Microbiome Therapeutics Consumption Market Share by Regions (2012-2025)
Figure 2025 Global Microbiome Therapeutics Consumption Market Share by Regions
Figure North America Microbiome Therapeutics Market Size (M USD) and Growth Rate (2012-2025)
Figure Europe Microbiome Therapeutics Market Size (M USD) and Growth Rate (2012-2025)
Figure Asia Pacific Microbiome Therapeutics Market Size (M USD) and Growth Rate (2012-2025)
Table Global Major Microbiome Therapeutics Developer Application
Table Global Microbiome Therapeutics R&D Investment (K USD) by Application (2012-2017)
Table Global Microbiome Therapeutics R&D Investment Share by Application (2012-2017)
Figure R&D Investment Market Share of Microbiome Therapeutics by Application (2012-2017)
Figure 2016 R&D Investment Market Share of Microbiome Therapeutics by Application
Figure Global Microbiome Therapeutics R&D Investment Growth by Application (2012-2017)
Table Global Microbiome Therapeutics Market by Pipeline
Table Phase 3 Product Introduction
Table Phase 2 Product Introduction
Figure Ammonia Oxidizing Bacteria (AOB) Pipeline
Figure LACTIN-V Pipeline
Figure CBM588 Pipeline
Table Phase 1 Product Introduction
Figure SER-262 Pipeline
Figure ABI-H0731 Pipeline
Figure Gemicel Pipeline
Figure VE303 Pipeline
Figure Blautix Pipeline
Figure RBX2660 Pipeline
Figure RBX7455 Pipeline
Table Seres Therapeutics Company Profile
Table Microbiome Therapeutics Product Information of Seres Therapeutics
Table Microbiome Therapeutics Investment (K USD), R&D Investment (K USD) and Product Information of Seres Therapeutics (2016 and 2017)
Table Assembly Biosciences Company Profile
Table Microbiome Therapeutics Product Information of Assembly Biosciences
Table Microbiome Therapeutics Investment (K USD), R&D Investment (K USD) and Product Information of Assembly Biosciences (2016 and 2017)
Table Synthetic Biologics Company Profile
Table Microbiome Therapeutics Product Information of Synthetic Biologics
Table Microbiome Therapeutics Investment (K USD), R&D Investment (K USD) and Product Information of Synthetic Biologics (2016 and 2017)
Table Interxon Company Profile
Table Microbiome Therapeutics Product Information of Interxon
Table Microbiome Therapeutics Investment (K USD), R&D Investment (K USD) and Product Information of Interxon (2016 and 2017)
Table PureTech Company Profile
Table Microbiome Therapeutics Product Information of PureTech
Table Microbiome Therapeutics Investment (K USD), R&D Investment (K USD) and Product Information of PureTech (2016 and 2017)
Table Synlogic Company Profile
Table Microbiome Therapeutics Product Information of Synlogic
Table Microbiome Therapeutics Investment (K USD), R&D Investment (K USD) and Product Information of Synlogic (2016 and 2017)
Table Enterome BioScience Company Profile
Table Microbiome Therapeutics Product Information of Enterome BioScience
Table Microbiome Therapeutics Investment (K USD), R&D Investment (K USD) and Product Information of Enterome BioScience (2016 and 2017)
Table 4D Pharma Company Profile
Table Microbiome Therapeutics Product Information of 4D Pharma
Table Microbiome Therapeutics Investment (K USD), R&D Investment (K USD) and Product Information of 4D Pharma (2016 and 2017)
Table Second Genome Company Profile
Table Microbiome Therapeutics Product Information of Second Genome
Table Microbiome Therapeutics Investment (K USD), R&D Investment (K USD) and Product Information of Second Genome (2016 and 2017)
Table AOBiome Company Profile
Table Microbiome Therapeutics Product Information of AOBiome
Table Microbiome Therapeutics Investment (K USD), R&D Investment (K USD) and Product Information of AOBiome (2016 and 2017)
Table C3 Jian Company Profile
Table Microbiome Therapeutics Product Information of C3 Jian
Table Microbiome Therapeutics Investment (K USD), R&D Investment (K USD) and Product Information of C3 Jian (2016 and 2017)
Table Rebiotix Company Profile
Table Microbiome Therapeutics Product Information of Rebiotix
Table Microbiome Therapeutics Investment (K USD), R&D Investment (K USD) and Product Information of Rebiotix (2016 and 2017)
Table MicroBiome Therapeutics LLC Company Profile
Table Microbiome Therapeutics Product Information of MicroBiome Therapeutics LLC
Table Microbiome Therapeutics Investment (K USD), R&D Investment (K USD) and Product Information of MicroBiome Therapeutics LLC (2016 and 2017)
Table Metabiomics Company Profile
Table Microbiome Therapeutics Product Information of Metabiomics
Table Microbiome Therapeutics Investment (K USD), R&D Investment (K USD) and Product Information of Metabiomics (2016 and 2017)
Table Ritter Pharmaceuticals Company Profile
Table Microbiome Therapeutics Product Information of Ritter Pharmaceuticals
Table Microbiome Therapeutics Investment (K USD), R&D Investment (K USD) and Product Information of Ritter Pharmaceuticals (2016 and 2017)
Table Symberix Company Profile
Table Microbiome Therapeutics Product Information of Symberix
Table Microbiome Therapeutics Investment (K USD), R&D Investment (K USD) and Product Information of Symberix (2016 and 2017)
Table OpenBiome Company Profile
Table Microbiome Therapeutics Product Information of OpenBiome
Table Microbiome Therapeutics Investment (K USD), R&D Investment (K USD) and Product Information of OpenBiome (2016 and 2017)
Table Azitra Company Profile
Table Microbiome Therapeutics Product Information of Azitra
Table Microbiome Therapeutics Investment (K USD), R&D Investment (K USD) and Product Information of Azitra (2016 and 2017)
Table Symbiotix Biotherapies Company Profile
Table Microbiome Therapeutics Product Information of Symbiotix Biotherapies
Table Microbiome Therapeutics Investment (K USD), R&D Investment (K USD) and Product Information of Symbiotix Biotherapies (2016 and 2017)
Table Osel Company Profile
Table Microbiome Therapeutics Product Information of Osel
Table Microbiome Therapeutics Investment (K USD), R&D Investment (K USD) and Product Information of Osel (2016 and 2017)
Table Metabogen Company Profile
Table Microbiome Therapeutics Product Information of Metabogen
Table Microbiome Therapeutics Investment (K USD), R&D Investment (K USD) and Product Information of Metabogen (2016 and 2017)
Figure typical phases from research to the market for a drug candidate
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound
Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report